{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:01:25Z","timestamp":1790172085382,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp;amp; Cancer"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pediatric patients with extracranial solid tumors (ST) receiving chemotherapy are at an increased risk for\n                      <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                      pneumonia (PJP). However, evidence guiding prophylaxis practices in this population is limited. A PJP\u2010related fatality at our institution highlighted inconsistent prescribing approaches and concerns about prophylaxis\u2010related toxicity, prompting the development of a quality improvement (QI) initiative to standardize PJP prophylaxis for patients with ST.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Procedure<\/jats:title>\n                    <jats:p>Our quality improvement (QI) initiative aimed to increase PJP prophylaxis initiation rates in pediatric patients (0\u201318\u00a0years) with newly diagnosed extracranial ST (excluding osteosarcoma) to over 90%, without associated chemotherapy delays or significant prophylaxis\u2010related toxicity. The initiative was designed using the Model for Improvement with monthly Plan\u2013Do\u2013Study\u2013Act cycles. Interventions included regular stakeholder engagement, education, and electronic health record (EHR)\u2010integrated prophylaxis prescriptions. Balancing measures, including discontinuation rates of prophylaxis, related toxicity, and chemotherapy delays, were assessed through clinician surveys and chart review. Kotter's 8\u2010Step Change Model secured engagement during planning and implementation of this 6\u2010month (April\u2013September 2024) initiative across inpatient and outpatient settings in a tertiary oncology center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PJP prophylaxis was initiated in 100% (\n                      <jats:italic>n<\/jats:italic>\n                      = 20) of eligible patients, an 88.7% relative improvement in coverage, compared to initiation rates of 53% in a historical cohort (\n                      <jats:italic>n<\/jats:italic>\n                      = 16\/30). No chemotherapy delays or discontinuations of prophylaxis due to toxicity were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A universal approach to PJP prophylaxis can be safely and effectively implemented in pediatric patients with ST without significant toxicity. Our experience highlights how change management models can effectively support the implementation of QI initiatives in pediatric oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/1545-5017.70015","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:35:37Z","timestamp":1767677737000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Quality Improvement Initiative to Standardize\n                    <i>Pneumocystis jirovecii<\/i>\n                    Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors"],"prefix":"10.1002","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8285-1715","authenticated-orcid":false,"given":"Kriti","family":"Kumar","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics The Hospital for Sick Children  Toronto Ontario Canada"},{"name":"University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7379-3439","authenticated-orcid":false,"given":"Denise M.","family":"Connolly","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics The Hospital for Sick Children  Toronto Ontario Canada"},{"name":"University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Kellington","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics The Hospital for Sick Children  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Zelunka","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics The Hospital for Sick Children  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Kerrigan","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics The Hospital for Sick Children  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-0359","authenticated-orcid":false,"given":"Furqan","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics The Hospital for Sick Children  Toronto Ontario Canada"},{"name":"University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-0871","authenticated-orcid":false,"given":"Paul C.","family":"Nathan","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics The Hospital for Sick Children  Toronto Ontario Canada"},{"name":"University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2452-5181","authenticated-orcid":false,"given":"Meredith S.","family":"Irwin","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics The Hospital for Sick Children  Toronto Ontario Canada"},{"name":"University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8852-1104","authenticated-orcid":false,"given":"Sarah","family":"Cohen\u2010Gogo","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology Department of Pediatrics The Hospital for Sick Children  Toronto Ontario Canada"},{"name":"University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V39.6.759.759"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.2820360612"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1980.02130190011004"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022\u20103476(73)80113\u20101"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197712292972602"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21202"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.10.021"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild\u20102020\u2010319997"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21577"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.3345\/kjp.2016.59.6.252"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003044"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild\u20102014\u2010307515"},{"key":"e_1_2_11_14_1","unstructured":"\u201c220\u2010Pneumocystis jiroveciiPneumonia (PJP) Prophylaxis in Immunocompromised Adults \u201deviQ last reviewed May 19 2023 https:\/\/www.eviq.org.au\/clinical\u2010resources\/side\u2010effect\u2010and\u2010toxicity\u2010management\/prophylaxis\u2010and\u2010treatment\/220\u2010pneumocystis\u2010jirovecii\u2010pneumonia\u2010pjp\u2010prophyl."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197712292972602"},{"key":"e_1_2_11_16_1","unstructured":"\u201cModel for Improvement \u201dInstitute for Healthcare Improvement accessed September 4 2025 https:\/\/www.ihi.org\/library\/model\u2010for\u2010improvement."},{"key":"e_1_2_11_17_1","unstructured":"A.Bedard \u201cThe 8\u2010Step Process for Leading Change | Dr. John Kotter \u201dKotter International Inc. accessed September 4 2025 https:\/\/www.kotterinc.com\/methodology\/8\u2010steps\/."},{"key":"e_1_2_11_18_1","unstructured":"\u201cHaematology\/Oncology (Cancer) \u201dSickKids accessed September 18 2025 https:\/\/www.sickkids.ca\/en\/care\u2010services\/clinical\u2010departments\/haematology\u2010oncology\u2010cancer\/."},{"key":"e_1_2_11_19_1","unstructured":"\u201cWith the Patient at the Heart \u201dEpic accessed September 18 2025 https:\/\/www.epic.com\/."},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2823"},{"key":"e_1_2_11_21_1","unstructured":"\u201cPlan\u2013Do\u2013Study\u2013Act (PDSA) Directions and Examples \u201dAHRQ last reviewed March2024 https:\/\/www.ahrq.gov\/health\u2010literacy\/improve\/precautions\/tool2b.html."},{"key":"e_1_2_11_22_1","unstructured":"\u201cDriver Diagram \u201d Institute for Healthcare Improvement accessed September 4 2025 https:\/\/www.ihi.org\/library\/tools\/driver\u2010diagram."},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.7.3.149"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2023-002522"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/QMH.0b013e3181bee19e"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102014\u2010005055"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/JHL.S289176"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jen.2016.03.028"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/emermed\u20102012\u2010201096"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nwh.2017.07.007"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2015.006882"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6087"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/03128962241307347"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12911\u2010020\u201001212\u2010z"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocy034"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2011.0131"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2011.000344"},{"key":"e_1_2_11_38_1","unstructured":"NCCN \u201cGuidelines Detail \u201dNCCN accessed November 17 2024 https:\/\/www.nccn.org\/guidelines\/guidelines\u2010detail?category=3&id=1457."},{"key":"e_1_2_11_39_1","unstructured":"\u201cRed Book: 2024\u20132027 Report of the Committee on Infectious Diseases \u201dAmerican Academy of Pediatrics 2024 https:\/\/publications.aap.org\/redbook\/book\/755\/Red\u2010Book\u20102024\u20102027\u2010Report\u2010of\u2010the\u2010Committee\u2010on."},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.09.013"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040331"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000606"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1545-5017.70015","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/1545-5017.70015","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1545-5017.70015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:13:43Z","timestamp":1790169223000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/1545-5017.70015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1002\/1545-5017.70015"],"URL":"https:\/\/doi.org\/10.1002\/1545-5017.70015","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"2025-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70015"}}